Efavirenz Capsules and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Efavirenz Capsules and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: efavirenz
Brand name: Sustiva
Synonyms: Efavirenz
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Efavirenz Capsules-Moxifloxacin
- Efavirenz Capsules-Moxifloxacin (Systemic)
- Efavirenz Capsules-Moxifloxacin Hydrochloride
- Efavirenz Capsules-Moxifloxacin Injection
- Efavirenz Capsules-Moxifloxacin Intravenous
- Efavirenz Capsules-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Efavirenz Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Efavirenz, emtricitabine, and tenofovir
- Moxetumomab pasudotox-tdfk Intravenous-Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
- Moxetumomab pasudotox-tdfk Intravenous-Efavirenz, lamivudine, and tenofovir
- Moxetumomab pasudotox-tdfk Intravenous-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Moxetumomab pasudotox-tdfk Intravenous-Effaclor Duo